able to contain the infection and their skin lesions are characterized by a predominance of CD8+ T cells and type 2 cytokines including interleukins 4 and 10. A key determinant of the T-cell cytokine response may be interleukin 12, which selectively favors expansion of CD4+ T cells producing interferon y. By understanding the factors that regulate T-cell and cytokine responses in leprosy, it should be possible to devise specific immunologic interventions in diseases of skin.] Invest DermatoI102: [828] [829] [830] [831] [832] 1994 lenged by intradermal injection of M. [eproe and induration is measured 3 weeks later. The test is positive in tuberculoid patients and negative in lepromatous patients.
It is widely agreed that T cells involved in cell-mediated immunity are pivotal in determining the outcome of infection with M.
[eprae, because skin test and lymphocyte reactivity are positive in tuberculoid patients but negative in lepromatous patients. Yet there is an interesting paradox in that CMI and humoral responses exhibit an inverse relationship. Anti -M. leprae antibodies are most elevated in patients with the lepromatous form of the disease, and therefore are not thought to playa role in protection. A goal of our studies was to determine whether the resistance to M. [eprae infection (associated with CMI) versus the susceptibility to M. [eprae infection (associated with humoral responses) could be correlated with distinct cytokine patterns.
THE TH1-TH2 PARADIGM
A major paradigm shift in how we think about immunoregulation resulted from the analysis of cytokine patterns produced by murine CD4+ T-cell clones [2] . T cells that produce interleukin 2 (IL-2) and interferon y (IFN-y), termed Th 1 cells, could be envisioned as contributing to CMI, whereas T cells that produce IL-4 and IL-5, termed Th2 cells, augment humoral responses. In murine models of intracellular infection, resistant versus susceptible immune responses appear to be regulated by these two T-cell sub populations [3 -5] . Th 1 cells preferentially activate macrophages to kill or inhibit the growth of the pathogen, resulting in mild or self-curing disease. In contrast, Th2 cells facilitate humoral responses and inhibit some cell-mediated immune responses, resulting in progressive infection. Through the investigation of the active lesions of leprosy, we have found that this paradigm may explain the dichotomy of responses to many human pathogens (Fig 2) .
CYTOKINE PATTERNS IN LEPROSY LESIONS
Initially, IL-2 was detected in leprosy lesions by monoclonal antibodies and immunoperoxidase techniques [6, 7] . All order of magnitude greater number of IL-2-containing cells were present in tuberculoid lesions as compared with lepromatous lesions. By in situ hybridization, it became readily apparent that IFN-y mRNA was also more strongly expressed in tuberculoid lesions [8] . These early studies indicated that the "Th 1 " cytokines were most prominent in the form of leprosy that is characterized by CMI to the pathogen .
To more fully probe patterns of cytokines in lesions at the ex- Figure 1 . The spectrum of leprosy.
tremes of the spectrum of leprosy, we exploited the power of polymerase chain reaction (PCR) to ana lyze the local cytokine pattern [9, 10) . The followed strategy was devised: 1) RNA was extracted from biopsy specimens; 2) polyadenylated mRNAs were reverse transcribed to obtain cytokine cDNAs; and 3) those cDNAs were detected with high sensitivity by PCR using cytokine specific primers. The discriminatory capacity of the PCR results was enharlCed by normalizing the PCR comparisons to specific CD30-chain mRNA found only in T cells. The striking observation was that clear differences in cytokine peR profiles were observed between tuberculoid and lepromatous lesions, and those differences were consistent across lesions of all patients: IL-2 and IFN-y mRNAs were markedly higher in tuberculoid lesions, whereas IL-4, IL-5, and IL-10 mRNAs were characteristic of lepromatous lesions (Fig 1B) . The cytokine patterns that were detected in the leprosy lesions are remarkably similar to the Th 1 and Th2 patterns of murine CD4+ cells. Th 1-like cytokine mRNAs were abundant in tuberculoid lesions, which are basically self-healing and characterized by resistance to growth of M. leprae. In marked contrast, Th2-like cytokine mRNAs were abundant in lepromatous lesions, correlating with immunologic unresponsiveness to M. leprae. Similar functional populations of human T cells were initially described in several experimental systems, including T-cell response to different antigens [11] [12] [13] , and in diseases including atopy [14) and Loa loa infection [15, 16) . Nevertheless, investigation of leprosy permitted the delineation of comparable human Th 1 and Th2 responses in response to a sillgle pathogen, which correlate with the clinical course of the infection.
The abundance ofIL-2 and IFN-y in tuberculoid lesions is likely to contribute to the resistant state of immunity in these patients. IFN-y is well known to enhance production of reactive oxygen and nitrogen intermediates [17) by macrophages and stimulate them to kill or restrict the growth of mycobacteria [18, 19] and other intracellular pathogens [20) . IFN-y also augments expression of HLA-DR and intercellular ad hesion molecule 1 (ICAM-I), which facilitates T -cell-accessory-cell interaction [21). IL-2 may contribute to the host defense by inducing the clonal expansion of immune-actiThl-Th2 PARADIGM 829 vated cytokine-producing T cells and augmenting the production of .
In contrast to the set of cytokine mRNAs present in tuberculoid lesions that might be involved in CMI and inflammation, those found to be increased in lepromatous lesions might be expected to contribute to the immune unresponsiveness and failure of macrophage activation in these individuals. IL-4 was increased in lepromatous lesions compared with tuberculoid lesions. IL-4 may contribute to the elevated anti-M. leprae antibodies in lepromatous patients via its role in differentiation and immunoglobulin class switching of B cells [23] as well as its abi lity to stimulate Th2 proliferation [24). IL-4 also has a negative immunoregulatory effect on CMI that could lead to enhanced bacterial growth, because it 1) blocks IL-2 -dependent proliferation of human T cells by downregulation of IL-2 receptors [25]; 2) abrogates both the IFN-ymediated activation of monocytes and their anti-leishmania! activity [26); 3) downregulates CD14 expression on monocytes and production of IL-IP and tumor necrosis factor a (TNF-a) [27); and 4) blocks macrophage nitric oxide generation necessary for killing intracellular pathogens [28] .
CYTOKINE PROFILES OF CD4 AND CDS T CLONES
What are the T-cell populations responsible for the production of these distinct cytokine patterns? Earlier immunoperoxidase and immunoflourescence studies had indicated differences in the CD4 : CDS ratio at the poles of the leprosy spectrum [6,7,29 -31) . The data from these studies indicate that in tuberculoid leprosy leSIOns the CD4+ population predominated, with a CD4: CDS ratio of 1.9: 1 '. wherea~ in the lepromatous lesions the CDS+ population predomlIlates with a CD4 : CDS ratio of 0.6 : 1. To gain insight into the molecular and cellular basis of T -cellmediated protection and suppression, as well as to correlate the cytokine patterns in lesions with functional subsets of CD4+ ar1d CDS+ T-cells, we examined the profile of cytokines produced by T-cell clones derived from patients across the spectrum of leprosy (35) . The patterns of cytokine secretion of these clones were compare? to the cytokine profiles of cells specific for other antigens beanng the. same surface phenotype, but differing in function. CD4 clones speCific for teta~1Us toxoid ar1d CDS major histocompatibility complex c.lass I -restncted T -cytotoxic cells specific for HLA-B27 were studied. The T-cell clones were stimulated via the T-cell receptor-CD3 complex using anti-CD3 monoclona! ar1tibodies, and the cytokines that they rel eased were measured [35) .
T-CELL CYTOKlNE PATTERNS
... 
EOSINOPHIL RESPONSES
All of the M . leprae-specific CD4+ clones obtained from tuberculoid patients produced IL-2, IFN-y, and granulocyte/macrophage colony-stimulating factor, but little or no IL-4 or IL-5, similar to the pattern of cytokines characteristic of murine Th 1 cells. These clones also lacked helper activity for antibody formation; we therefore designated them as "type 1" CD4+ T cells. The CD4+ tetanus toxoid clones produced low levels of IFN-y and IL-2, but high levels of IL-4 and IL-5, a pattern similar to that of Th2 cells. These clones were found to have B-cell helper activity and were designated as "type 2" CD4+ T cells. Thus, functionally different CD4+ T cells from strongly antigen-reactive donors can be subtyped into two groups, similar to the murine counterparts, based on cytokine patterns.
Similarly, we were able to define subpopulations of CD8+ T cells based on their cytokine pattern. The majority of the CD8+ all oreactive T-cytotoxic clones tested secreted IFN-y, but made no detectable IL-4 or IL-5 . Of particular interest, the pattern of cytokine production by the CD8+ T -suppressor clones was characterized by high levels of IL-4 and low levels of IFN-y. Based on patterns of cytokine secretion, particularly of IL-4, the data suggest that the human CD8 population can also be divided into two functional subsets, which we designate as "type 1" and "type 2" CD8+ T cells.
IL-4 facilitated the growth of CD8+ T cells and T cell clones from lepromatous donors, suggesting that it may act as an autocrine growth factor for the CD8+ type 2 subset [36] . The critical role for IL-4 in mediating suppression of CD4+ T-cell responses was shown using neutralizing anti -IL-4 antibodies [35] . We also found that the suppressor activity of CD8+ type 2 cells could be abrogated by the addition of anti-IL-4 antibodies to the cultures.
It is a well known immunologic generalization that a dichotomy exists between antibodies to a pathogen and cell-mediated immunity. As a case in point, lepromatous leprosy patients, lacking CMI, have significantly higher levels of anti-M. leprae antibodies than tuberculoid patients. These data and the results of murine infection models can best be reconciled by appreciating that IL-4 has the capacity not only to enhance antibody formation, but also to depress multiple components of CM! required for protection. However, it should be noted that there may be significant contributions to the outcome of infection by other cytokines. More likely it is the matrix of cytokines that determine the utlimate biologic response at the locus of infection, protective immunity , and/or immunopathology.
A ROLE FOR IL-I0
Although IL-I0 mRNAs were prominent in lepromatous lesions, the T-cell clones from the lesions produced only small amounts of IL-10 protein [35, 36] . The presence in lepromatous lesions of IL-10, a cytokine that can down-regulate cytokine production by CD4 T cells in the relative absence of IFN-y or IL-2, suggests a possible role for this cytokine in the specific immunologic unresponsiveness to M . leprae antigens [37, 38] . To define more precisely the role of IL-10 in human infection, we studied in vitro responses toM. leprae [36] . M. leprae triggered IL-l 0 release from peripheral blood mononuclear cells of patients and healthy donors; the predominant source of the IL-I0 was found to be macrophages. Neutralizing anti -IL-10 monoclonal antibodies significantly enhanced M. leprae-specific T-cell proliferation and release of TNF-a, granulocyte/macrophage colony-stimulating factor, and IFN-y. These data indicate that M. leprae induces IL-l 0 production, which inhibits T-cell proliferation and the release of cytokines that have anti-mycobacterial properties.
REVERSING CYTOKINE PATTERNS
Leprosy is not a static disease but an extremely dynamic condition in which immune changes alter the clinical manifestations, in the form of "reactional states." These reactional states provide a window onto the dynamic immune events associated with immunoregulation in human disease. Reversal reactions are generally known to be naturally occurring delayed-type hypersensitivity (DTH) responses to M. leprae, associated with clearance of bacilli from lesions THE JOURNAL OF INVESTIGATIVE DERMATOLOGY and upgrading towards the tuberculoid pole [39] [40] [41] [42] [43] . The onset of reversal reactions is associated with the emergence ofT-ceil responsiveness to M. leprae. Reversal reaction lesions are characterized by the influx of CD4+ T cells [44] . W e analyzed the dynamic changes in cytokine patterns by studying biopsy specimens from patients before the onset of reversal reaction and during the reaction [10] . As patients with reversal reaction upgrade from the lepromatous pole, we found a concomitant switch from type 2 to type 1 cytokine production locally. These data provide clear evidence that DTH responses involve the influx of T cells secreting type 1 cytokines. Furthermore, because the cytokine pattern changes during a naturally occurring reaction, it should be possible to devise immunotherapeutic tools to artificially reverse the cytokine profile. In fact, cutaneous administration of either IL-2 or IFN-y to lepromatous patients results in some clearance of bacilli from lesions [19, 45] , although there is little or no gain in immunologic memory.
LEARNING FROM LEISHMANIASIS
Leishmaniasis, like leprosy, is not a single disease entity, but a set of clinical entities each with a differing immunopathogenesis. These different clinical presentations may comprise an immunologic spectrum [46] . Patients with localized cutaneous leishmaniasis (LCL) have few skin lesions in which the growth of the parasite is restricted. In contrast, patients with diffuse cutaneous leishmaniasis (DCL) have widely disseminated lesions and the growth of the parasite appears to be unabated. The Montenegro test, a DTH response to intradermal challenge with Leishmania antigen is positive in LCL patients and negative in DCL patients. A minority of LCL patients heal, but subsequently relapse to the mucocutaneous (MCL) form. Patients with MCL may fall somewhere in between the two poles of the LCL-DCL spectrum, having some resistance against disseminated infection, but not being able to fully eliminate the parasite, a situation resulting in chronic destructive lesions.
By PCR we determined that the type 1 cytokine pattern was present in the Montenegro reaction and the self-healing LCL group [47] . The abundance of IL-2, IFN-y, and lymphotoxin is likely to contribute to the resistant state of immunity and elimination of parasites. On the other hand, MCL lesions appear to be characterized by a mixture of type 1 and type 2 cytokines. The greatest difference found in MCL versus LCL lesions was the several orders of magnitude greater amount of IL-4 mRNA in MCL lesions [48] . Although IFN-y is present, the levels of IL-4 may be sufficient to inhibit macrophage function so that all the parasites are not eliminated and the infection persists. In DCL lesions, the level ofIL-4 is greatest, so that the parasite's growth is unabated. These data indicate the crucial role of IL-4 in determining outcome in cutaneous leishmaniasis. Furthermore, these studies provide evidence that the pathogenesis of human leishmaniasis is associated with distinct cyto kine patterns that conform to the Th 1-Th2 paradigm.
To gain insight into the functional role of the CD4+ and CD8+ subsets in LCL lesions in contributing to the observed cytokine patterns, we examined the cytokine mRNAs of the sorted populations from lesions [49] . The CD4+ subset was characterized by high levels of IFN-y and lymphotoxin mRNAs, thereby conforming to the type 1 cytokine pattern. In contrast, the CD8+ subset was characterized by high levels of IL-4 mRNAs with weak expression of IFN-y and lymphotoxin RNAs, consistent with a type 2 cytokine pattern. Finally, IL-10 mRNA was present in both subsets but more strongly expressed in the CD8+ subset. The outcome of the human immune response to leishmania, in a manner analogous to mycobacteria, may depend on the balance between CD4+ type 1 T cells and CD8+ type 2 T cells.
FACTORS THAT INFLUENCE THE CYTOKINE PATTERN
One of the major issues in immunology today is the elucidation of the key factors that determine or bias Th 1 versus Th2 responses. In the murine model of leishmaniasis, distinct antigen fractions of Leishmania, as well as antigen dose, select the functional T-cell population [50] . Yet more current data in a mouse model indicates that identical T-cell receptors, hence identical antigens, can give rise to the Th 1 versus Th2 patterns [51] . Our studies of human leishmaniasis indicate that the human T-cell populations responsible for the Th 1 and Th2 patterns bear distinct T-cell receptors and hence may recognize distinct antigens [49] .
In mouse models, the antigen-presenting cell may be a determining factor. Macrophages may preferentially present antigen to Th 1 cells, but B-cells present antigen to Th2 cells [52] . It is noteworthy that Langerhans cells, powerful antigen-presenting cells of the skin, can present to both Thl and Th2 cells, but when ultraviolet irradiated present only to Th2 cells [53] . Cytokine patterns may be specific according to anatomic location: T cells in lymphoid org~ns draining nonmucosal tissue sites produce IL-2 whereas those draming mucosal sites produce IL-4 [54] . It is also important to consider the major histocompatibility complex genotype that may select particular T-cell populations [55] . In leprosy, the major histocompatibility complex restricting element may be critical: the majority of CD4 type 1 cells are restricted by HLA-DR [56] , but the CDS T -suppressor type 2 cells are restricted by HLA-DQ [57] .
Many immunologists consider that "natural immunity" is involved in determining outcome in that cells other than T cells may rapidly produce cytokines that bias the T-cell cytokine response [58] . Infected macrophages usually release IFN-a and IL-12, which activate natural killer cells to release lFN-y, with a subsequent bias towards a Th 1 response [59] . In vivo, susceptible mice are cured of L. major infection when recombinant IL-2 is administered before or at the time of infection [60, 61] .
IL-12: A KEY DETERMINANT?
We investigated the role ofIL-12 in regulating type 1 T-cell responses in human infection by employing leprosy as a model [62] . The local production ofIL-12 in leprosy lesions was evaluated using the polymerase chain reaction. IL-12 is a 70-kD heterodimer produced by macrophages. The constitutively produced IL-12 p35 mRNA was present at equivalent levels in both forms of the disease. In contrast, IL-12 p40 mRNA levels were significantly higher in tuberculoid than lepromatous lesions. Therefore, the local expression of IL-l2 was greatest in the group of patients characterized by type 1 cytokine responses.
One characteristic of IL-12 is its potent T-cell growth factor activity [63] . We found that T-cell proliferation to M. leprae was dependent on the endogenous production of IL-12 in that we could block proliferation in vitro by the addition of neutralizing IL-12 antibodies. IL-12 has been shown to direct T cells in a primary response towards a type 1 cytokine pattern [64] [65] [66] . A striking finding of our analysis ofT-cell res"ponses in leprosy was that rIL-12 induced proliferation of CD4+ type 1 cell clones from tuberculoid lesions but not CDS+ type 2 cell clones from lepromatous lesions. All clones proliferated in response to rIL-2. Therefore, a mechanism by which IL-12 may contribute to CMl is via the preferential expansion of differentiated T cells committed to the type 1 cytokine pattern.
Can IL-2 be used as an immunotherapeutic adjuvant to reverse T-cell unresponsiveness and induce type 1 cytokine responses? Towards this goal, we explored whether rlL-12 could potentiate antigen-induced T-cell responses and augment CMl in unresponsive lepromatous patients. We observed an IL-12-dependent enhancement ofT-cell responses in lepromatous patients that could be attributed to an increase in CD4+ T cells. Furthermore, IL-12 induced a preferential increase in the capacity ofT cells to produce the type 1 cytokine, IFN-y, versus the type 2 cytokine, IL-4. Perhaps more intriguing was the ability of anti-IL-10 to augment rIL-12 plus M. leprae-stimulated T-cell proliferation in some patients to levels approaching those of tuberculoid patients. It should be noted that T-cell responses and IFN -y production could not be augmented in all lepromatous patients. Therefore, additional factors may be responsible for inducing T-cell responsiveness and type 1 cytokine responses to infectious pathogens. Yet our data and studies of human immunodeficiency virus infection [67] indicate the potential usefulness as IL-12 in the immunotherapy of infectious disease.
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Perhaps combination immunotherapy, employing antagonists to "negative" regulatory cytokines, would be a more effective strategy in combating human infectious disease [66,6S] . Hopefully, such approaches can help patients with leprosy and other devastating diseases. 
This work was

